Sentinel Lymph Node Biopsy Alone Matches full Lymphadenectomy for disease free survival in Early Cervical Cancer: NEJM
Written By : Dr. Shravani Dali
Published On 2025-11-14 15:00 GMT | Update On 2025-11-14 15:00 GMT
Advertisement
Researchers have found in a new study that in early-stage cervical cancer, sentinel lymph node biopsy (SLNB) alone was noninferior to full pelvic lymphadenectomy for disease-free survival, while also resulting in fewer postoperative complications. The study, published in the New England Journal of Medicine, enrolled patients with early-stage cervical cancer who underwent either SLNB or standard full lymphadenectomy. The findings indicate that SLNB provides comparable oncologic outcomes while minimizing the morbidity associated with extensive lymph node removal, such as lymphedema, nerve injury, and longer recovery times.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.